Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer

被引：0
|
作者：
Yi-Rong Liu
Yi-Zhou Jiang
Xiao-En Xu
Ke-Da Yu
Xi Jin
Xin Hu
Wen-Jia Zuo
Shuang Hao
Jiong Wu
Guang-Yu Liu
Gen-Hong Di
Da-Qiang Li
Xiang-Huo He
Wei-Guo Hu
Zhi-Ming Shao
机构：
[1] Fudan University Shanghai Cancer Center,Department of Breast Surgery
[2] Fudan University Shanghai Cancer Center,Cancer Institute
[3] Fudan University,Department of Oncology, Shanghai Medical College
[4] Fudan University,Institutes of Biomedical Sciences
来源：
Breast Cancer Research | / 18卷
关键词：
Molecular subtypes; Messenger RNA; Long non-coding RNA; Triple-negative breast cancer; Transcriptome analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer
    Liu, Yi-Rong
    Jiang, Yi-Zhou
    Xu, Xiao-En
    Yu, Ke-Da
    Jin, Xi
    Hu, Xin
    Zuo, Wen-Jia
    Hao, Shuang
    Wu, Jiong
    Liu, Guang-Yu
    Di, Gen-Hong
    Li, Da-Qiang
    He, Xiang-Huo
    Hu, Wei-Guo
    Shao, Zhi-Ming
    [J]. BREAST CANCER RESEARCH, 2016, 18
  • [2] Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific IncRNAs of triple-negative breast cancer
    Liu, Y-R
    Jiang, Y-Z
    Xu, X-E
    Zuo, W-J
    Yu, K-D
    Jin, X.
    Hu, X.
    Wu, J.
    Liu, G-Y
    Di, G-H
    Shao, Z-M
    [J]. CANCER RESEARCH, 2016, 76
  • [3] Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
    Burstein, Matthew D.
    Tsimelzon, Anna
    Poage, Graham M.
    Coyington, Kyle R.
    Contreras, Alejandro
    Fuqua, Suzanne A. W.
    Sayage, Michelle I.
    Osborne, C. Kent
    Hilsenbeck, Susan G.
    Chang, Jenny C.
    Mills, Gordon B.
    Lau, Ching C.
    Brown, Powel H.
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (07) : 1688 - 1698
  • [4] Molecular subtypes of triple-negative breast cancer: understanding of subtype categories and clinical implication
    Lee, Yong-Moon
    Oh, Man Hwan
    Go, Jai-Hyang
    Han, Kyudong
    Choi, Song-Yi
    [J]. GENES & GENOMICS, 2020, 42 (12) : 1381 - 1387
  • [5] Molecular subtypes of triple-negative breast cancer: understanding of subtype categories and clinical implication
    Yong-Moon Lee
    Man Hwan Oh
    Jai-Hyang Go
    Kyudong Han
    Song-Yi Choi
    [J]. Genes & Genomics, 2020, 42 : 1381 - 1387
  • [6] Triple Negative Breast Cancer: Molecular Subtype-Specific Immune Landscapes with Therapeutic Implications
    Syrnioti, Antonia
    Petousis, Stamatios
    Newman, Lisa A.
    Margioula-Siarkou, Chrysoula
    Papamitsou, Theodora
    Dinas, Konstantinos
    Koletsa, Triantafyllia
    [J]. CANCERS, 2024, 16 (11)
  • [7] Integrative Analysis Reveals Subtype-Specific Regulatory Determinants in Triple Negative Breast Cancer
    Huang, Shujun
    Xu, Wayne
    Hu, Pingzhao
    Lakowski, Ted M.
    [J]. CANCERS, 2019, 11 (04)
  • [8] Transcriptomic Analysis of Subtype-Specific Tyrosine Kinases as Triple Negative Breast Cancer Biomarkers
    Limsakul, Praopim
    Choochuen, Pongsakorn
    Charupanit, Gorn
    Charupanit, Krit
    [J]. CANCERS, 2023, 15 (02)
  • [9] Identifying specific inhibitors of triple-negative breast cancer subtypes
    Robles, A. J.
    Cai, S.
    Du, L.
    Shaffer, C. V.
    Grkovic, T.
    Risinger, A. L.
    O'Keefe, B. R.
    Cichewicz, R. H.
    Mooberry, S. L.
    [J]. PLANTA MEDICA, 2016, 82
  • [10] Comprehensive Analysis Identifies Variability in PI3K Pathway Alterations in Triple-Negative Breast Cancer Subtypes
    Basho, Reva K.
    Zhao, Li
    White, Jason B.
    Huo, Lei
    Bassett, Roland L.
    Mittendorf, Elizabeth A.
    Thompson, Alastair
    Litton, Jennifer K.
    Ueno, Naoto
    Arun, Banu
    Lim, Bora
    Valero, Vicente
    Tripathy, Debu
    Zhang, Jianhua
    Adrada, Beatriz E.
    Santiago, Lumarie
    Ravenberg, Elizabeth
    Seth, Sahil
    Yam, Clinton
    Moulder, Stacy L.
    Damodaran, Senthil
    [J]. JCO PRECISION ONCOLOGY, 2024, 8
12345